Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > I try to remind myself

<< Previous

Bullboard Posts

Next >>

Comment by Wino115on Nov 29, 2021 3:58pm

129 Views

Post# 34177248

RE:RE:RE:RE:I try to remind myself

There's probably still lots of shareholders who have peripheral holdings, showing either a loss or that it was up a decent amount just for the year, so why not well. I can't say I'm helping as I put in below market offers and the desperate sellers hit my buy orders.

I'm looking at this typical year end dump as a spring that will sprong Jan 2 or sooner! There's been no news so if you know what's actually going on, that is actually either neutral or positive. The neutral is they stuck the level where they were -- either 1.5x or 2x -- and are now getting those final 6 patients lined up with that dose. If no SAEs, they're ready for the 1b efficacy study. That's not bad news, that's good news. Onward and Upward!